Lundbeck's Ludovic Otterbein on Bottlenecks and Best Practices in Compound Management

Add bookmark

Lundbeck's Ludovic Otterbein on Bottlenecks and Best Practices in Compound Management

Add bookmark

Every company has compound collections of different sizes, but we all face the same challenge of the rising cost of R&D. - Ludovic Otterbein

Ludovic Otterbein, Head of Global Compound Management and Analytical Chemistry at at H. Lundbeck A/S, speaks to Andrea Charles from Pharma IQ, about the main reasons behind compromised sample integrity, what best practices provide true value in compound management and the biggest bottlenecks the industry is facing. Otterbein also shares his insights on whether economic worries will hold back Operation Excellence in pharmaceutical R&D and his top tip for someone new to the field.

[inlinead]

Have Your Say
Rate this feature and give us your feedback in the comments section below

Upcoming Events

Pharma Contract Manufacturing

23 - 25 March 2026

Mercure Hotel MOA Berlin, Germany

Pharma Contract Manufacturing

SmartLab Exchange USA

April 21 - 22, 2026

Philadelphia, USA

SmartLab Exchange USA

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended